Role for c-Jun N-terminal kinase in β-cell recovery from nitric oxide-mediated damage

Endocrinology

Volumn 144, Issue 8, 2003, Pages 3415-3422

  Scarim, Anna L ^a   Nishimoto, Sheri Y ^a   Weber, Sarah M ^a   Corbett, John A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (N,N DIETHYLAMINO)DIAZEN 1 IUM 1,2 DIOLATE; ACONITATE HYDRATASE; CYCLIC GMP; GUANYLATE CYCLASE; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL DAMAGE; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; INSULIN RELEASE; MITOCHONDRION; NONHUMAN; OXIDATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM;

ACONITATE HYDRATASE; ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; GUANYLATE CYCLASE; HYDRAZINES; INSULINOMA; INTERLEUKIN-1; ISLETS OF LANGERHANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITROGEN OXIDES; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

EID: 0042315383     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-0112     Document Type: Article

References (39)

1. Gepts W 1965 Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633
2. Bach JF 1994 Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516-542
3. Rabinovitch A, Suarez-Pinzon WL 1998 Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55:1139-1149
4. Mandrup-Poulsen T 1996 The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029
5. Heitmeier MR, Corbett JA 2000 Cytotoxic role of nitric oxide in diabetes. In: Ignarro LJ, ed. Nitric oxide biology and pathobiology. San Diego: Academic Press; 785-810
6. Hughes JH, Colca JR, Easom RA, Turk J, McDaniel ML 1990 Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 86:856-863
7. Mandrup-Poulsen T 2001 β-Cell apoptosis: stimuli and signaling. Diabetes 50:S58-S63
8. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N 1996 The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic β cells. Diabetologia 39:875-890
9. Corbett JA, McDaniel ML 1994 Reversibility of interleukin-1 β-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem J 299:719-724
10. Corbett JA, Wang JL, Hughes JH, Wolf BA, Sweetland MA, Lancaster Jr JR, McDaniel ML 1992 Nitric oxide and cyclic GMP formation induced by interleukin 1 β in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J 287:229-235
11. Corbett JA, Kwon G, Turk J, McDaniel ML 1993 IL-1 β reduces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry 32:13767-13770
12. Corbett JA, Wang JL, Sweetland MA, Lancaster Jr JR, McDaniel ML 1992 Interleukin 1 β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. Evidence for the β-cell as a source and site of action of nitric oxide. J Clin Invest 90:2384-2391
13. Kay TW, Thomas HE, Harrison LC, Allison J 2000 The β cell in autoimmune diabetes: many mechanisms and pathways of loss. Trends Endocrinol Metab 11:11-15
14. Scarim AL, Heitmeier MR, Corbett JA 1997 Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1β. Endocrinology 138:5301-5307
15. Thomas HE, Kay TW 2001 How β cells die in type 1 diabetes. Curr Direct Autoimmun 4:144-170
16. Flodstrom M, Tyrberg B, Eizirik DL, Sandier S 1999 Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 48:706-713
17. Andersson AK, Flodstrom M, Sandler S 2001 Cytokine-induced inhibition of insulin release from mouse pancreatic β-cells deficient in inducible nitric oxide synthase. Biochem Biophys Res Commun 281:396-403
18. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA 1998 IL-1 produced and released endogenously within human islets inhibits β cell function. J Clin Invest 102:516-526
19. Corbett JA, McDaniel ML 1995 Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568
20. Thomas HE, Darwiche R, Corbett JA, Kay TWH 2002 Interleukin-1 plus γ-interferon-induced pancreatic β-cell dysfunction is mediated by β-cell nitric oxide production. Diabetes 51:311-316
21. Comens PG, Wolf BA, Unanue ER, Lacy PE, McDaniel ML 1987 Interleukin I is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes 36:963-970
22. Scarim AL, Heitmeier MR, Corbett JA 1998 Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets. Endocrinology 139:5050-5057
23. McDaniel ML, Colca JR, Kotagal N, Lacy PE 1983 A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. Methods Enzymol 98:182-200
24. Heitmeier MR, Scarim AL, Corbett JA 1997 Interferon-γ increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. J Biol Chem 272:13697-13704
25. Becker-Hapak M, McAllister SS, Dowdy SF 2001 TAT-mediated protein transduction into mammalian cells. Methods (Duluth) 24:247-256
26. Vocero-Akbani A, Chellaiah MA, Hruska KA, Dowdy SF 2001 Protein transduction: delivery of Tat-GTPase fusion proteins into mammalian cells. Methods Enzymol 332:36-49
27. Ignarro LJ 1992 Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism. Biochem Soc Trans 20:465-469
28. Browning DD, McShane MP, Marty C, Ye RD 2000 Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase. J Biol Chem 275:2811-2816
29. Maggi Jr LB, Sadeghi H, Weigand C, Scarim AL, Heitmeier MR, Corbett JA 2000 Anti-inflammatory actions of 15-deoxy-δ 12, 14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes 49:346-355
30. Misler S, Barnett DW, Gillis KD, Pressel DM 1992 Electrophysiology of stimulus-secretion coupling in human β-cells. Diabetes 41:1221-1228
31. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV 2000 Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New Engl J Med 343:230-235
32. Chong MM, Thomas HE, Kay TW 2002 Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic β cells to tumor necrosis factor. J Biol Chem 277:27945-27952
33. Cottet S, Dupraz P, Hamburger F, Dolci W, Jaquet M, Thorens B 2001 SOCS-1 protein prevents Janus kinase/STAT-dependent inhibition of β cell insulin gene transcription and secretion in response to interferon-γ. J Biol Chem 276:25862-25870
34. Cottet S, Dupraz P, Hamburger F, Dolci W, Jaquet M, Thorens B 2002 cFLIP protein prevents tumor necrosis factor-α-mediated induction of caspase-8-dependent apoptosis in insulin-secreting βTc-Tet cells. Diabetes 51:1805-1814
35. Dupraz P, Cottet S, Hamburger F, Dolci W, Felley-Bosco E, Thorens B 2000 Dominant negative MyD88 proteins inhibit interleukin-1β/interferon-γ-mediated induction of nuclear factor κ B-dependent nitrite production and apoptosis in β cells. J BiolChem 275:37672-37678
36. Giannoukakis N, Rudert WA, Trucco M, Robbins PD 2000 Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an Iκ B repressor. J Biol Chem 275:36509-36513
37. Bottino R, Balamurugan AN, Bertera S, Pietropaolo M, Trucco M, Piganelli JD 2002 Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes 51:2561-2567
38. Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB 1998 Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1β-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 101:1811-1820
39. 2. Am J Physiol Endocrinol Metab 284:E883-E891